Kurs & Likviditet
-2,84%
|
28,7 MNOK
Kursutveckling och likviditet under dagen för detta pressmeddelande
Kalender
2024-08-30 | Kvartalsrapport 2024-Q2 |
2024-04-12 | Ordinarie utdelning TRMED 0.00 NOK |
2024-04-11 | Årsstämma 2024 |
2024-02-28 | Bokslutskommuniké 2023 |
2023-08-31 | Kvartalsrapport 2023-Q2 |
2023-04-27 | Ordinarie utdelning TRMED 0.00 NOK |
2023-04-26 | Årsstämma 2023 |
2023-02-28 | Bokslutskommuniké 2022 |
2022-08-31 | Kvartalsrapport 2022-Q2 |
2022-04-29 | Ordinarie utdelning TRMED 0.00 NOK |
2022-04-28 | Årsstämma 2022 |
2022-03-01 | Bokslutskommuniké 2021 |
2021-11-18 | 15-10 2021-Q3 |
2021-08-26 | Kvartalsrapport 2021-Q2 |
2021-05-26 | Kvartalsrapport 2021-Q1 |
2021-04-28 | Årsstämma 2021 |
2021-04-16 | Ordinarie utdelning TRMED 0.00 NOK |
2021-03-22 | Extra Bolagsstämma 2021 |
2021-02-18 | Bokslutskommuniké 2020 |
2020-11-19 | Kvartalsrapport 2020-Q3 |
2020-10-21 | Extra Bolagsstämma 2020 |
2020-08-27 | Kvartalsrapport 2020-Q2 |
2020-06-11 | Ordinarie utdelning TRMED 0.00 NOK |
2020-06-10 | Årsstämma 2020 |
2020-05-26 | Kvartalsrapport 2020-Q1 |
2020-02-27 | Bokslutskommuniké 2019 |
2019-11-19 | Kvartalsrapport 2019-Q3 |
2019-08-22 | Kvartalsrapport 2019-Q2 |
2019-05-23 | Kvartalsrapport 2019-Q1 |
2019-04-26 | Ordinarie utdelning TRMED 0.00 NOK |
2019-04-25 | Årsstämma 2019 |
2019-02-18 | Extra Bolagsstämma 2019 |
2018-08-22 | Kvartalsrapport 2018-Q2 |
2018-05-31 | Ordinarie utdelning TRMED 0.00 NOK |
2018-05-30 | Kvartalsrapport 2018-Q1 |
2018-05-30 | Årsstämma 2018 |
2018-02-27 | Bokslutskommuniké 2017 |
2017-12-20 | Extra Bolagsstämma 2017 |
2017-11-22 | Kvartalsrapport 2017-Q3 |
2017-08-23 | Kvartalsrapport 2017-Q2 |
2017-05-26 | Ordinarie utdelning TRMED 0.00 NOK |
2017-05-24 | Kvartalsrapport 2017-Q1 |
2017-05-24 | Årsstämma 2017 |
2017-02-28 | Bokslutskommuniké 2016 |
2016-11-23 | Kvartalsrapport 2016-Q3 |
2016-10-12 | Extra Bolagsstämma 2016 |
2016-08-24 | Kvartalsrapport 2016-Q2 |
2016-05-31 | Kapitalmarknadsdag 2016 |
2016-05-20 | Ordinarie utdelning TRMED 0.00 NOK |
2016-05-19 | Årsstämma 2016 |
2016-05-19 | Kvartalsrapport 2016-Q1 |
2016-02-26 | Bokslutskommuniké 2015 |
2015-11-17 | Kapitalmarknadsdag 2015 |
2015-10-21 | Kvartalsrapport 2015-Q3 |
2015-08-26 | Kvartalsrapport 2015-Q2 |
2015-05-27 | Kvartalsrapport 2015-Q1 |
2015-03-09 | Årsstämma 2015 |
2014-11-12 | Extra Bolagsstämma 2014 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
2023-06-28 16:30:34
Reference is made to the stock exchange announcement made by Nordic Nanovector
ASA ("Nordic Nanovector" or the "Company") on 6 June 2023 regarding the
Company's acquisition of Thor Medical AS (the "Transaction"), with approval of
the Transaction from the Company's annual general meeting (the "AGM") as one of
the closing conditions.
Please find attached the minutes from the AGM. All items on the agenda were
approved by the AGM, including the agenda items relating to the Transaction.
The Transaction is expected to be consummated on or around 3 July 2023.
About Nordic Nanovector
Nordic Nanovector is committed to develop and deliver innovative therapies to
patients to address major unmet medical needs and advance cancer care.
This information is subject of the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
Ludvik Sandnes, Interim CEO & CFO
Cell: +47 907 43 017
Email: ir@nordicnanovector.com